Valencia Technologies Unveils Medical Device And Crowdfunding Offering Simultaneously On New Website

VALENCIA, Calif., Nov. 3, 2014 /PRNewswire/ -- Valencia Technologies Corporation (“Valencia”) launched a crowdfunding campaign on November 3, 2014 on its website, sharing with the public its technology, financials, issued and pending patents, and its business plans. Company to take in funds for the $30M offering at $6 per share from accredited investors only.

New SEC rules have recently enabled private companies like Valencia to seek investment through general solicitation. Valencia relies on Section 4(a)(2) of the Securities Act and Regulation D, Section 506(c).

The technology is a coin-sized pacemaker-like device placed subcutaneously in the forearm in a 20-minute office procedure for the treatment of hypertension. The basic technology is applicable to other chronic conditions for which the Company has applied for patents.

The early clinical results of Valencia’s international, double-blinded, and controlled study are positive. Results show clinical significance compared with baseline and compared with an implanted control group. More than 38 patients have been implanted with the device.

Valencia Technologies Corporation is a medical technology company located in Valencia, California, and founded and led by Jeff Greiner, the former operational leader of Advanced Bionics from its infancy to over 2500 employees.

For more information on Valencia and the current offering, please visit our website at www.valenciatechnologies.com.

Find us on:
LinkedIn
Facebook
Twitter
YouTube

SOURCE Valencia Technologies Corporation